Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2979-2984

  Morita, K ^a   Miura, M ^a   Paolone, D R ^a   Engeman, T M ^a   Kapoor, A ^a   Remick, D G ^a   Fairchild, R L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MACROPHAGE CHEMOTACTIC FACTOR; MONOCYTE CHEMOTACTIC PROTEIN; MONOKINE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0035451682     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2979     Document Type: Article

References (34)

1. The registry of the international society for heart and lung transplantation: Fifteenth official report, 1998
2. Chronic rejection in human allografts
3. The impact of an acute rejection episode on long-term renal allograft survival
4. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
5. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agent in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
6. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys-correlation with intragraft events
7. Regulation of endothelial VCAM-1 expression in murine cardiac grafts: Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-α or IL-4 and is not required for allograft rejection
8. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1
9. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies
10. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (Enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group
11. Chemokines
12. Chemokines: Function, regulation and alteration of inflammatory responses
13. Induction of chemokine gene expression during allogencic skin graft rejection
14. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts
15. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts
16. Epithelialderived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection
17. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
18. + T cells
19. Human Mig chemokine: Biochemical and functional characterization
20. Groα mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity
21. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4
22. Primarily vascularized allografts of hearts in mice
23. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
24. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1
25. Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
26. Cytokine and T cell receptor gene expression at the site of allograft rejection
27. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-α genes in rejecting skin allografts
28. Characterization of the production of monocyte chemoattractant protein-1] and IL-8 in an allogeneic immune response
29. The production of chemotactic cytokines in an allogeneic response: The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3
30. Plasma activation of neutrophil CD18 after skeletal muscle ischemia: A potential mechanism for late systemic injury
31. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: Inhibition by a soluble P-selectin ligand
32. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent
33. Expression and regulation of human neutrophil-derived macrophage inflammatory protein-1
34. T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo